Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma.

Fei-Yi-Fan WangSi-Yi Wang-GouHang CaoNian JiangQi YangQi HuangChun-Hai HuangXue-Jun Li

Published in: Cancer communications (London, England) (2020)

EGFL7 is a potential diagnostic biomarker and therapeutic target of glioma. Selumetinib could target the EGFR pathway and possibly improve the prognosis of EGFR-positive glioma.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
small cell lung cancer
mass spectrometry
genome wide
human health
growth factor
dna methylation
risk assessment